Pyxis Oncology (PYXS) Institutional Ownership → Don’t Miss Out on the AI Gold Rush That’s Just Getting Started (From Banyan Hill Publishing) (Ad) Free PYXS Stock Alerts $4.64 +0.11 (+2.43%) (As of 10:46 AM ET) Add Compare Share Share OwnershipStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Institutional Ownership Changes (13F Filings) for Pyxis Oncology (NASDAQ:PYXS)CurrentInstitutional OwnershipPercentage39.09%Number ofInstitutional Buyers(last 12 months)15TotalInstitutional Inflows(last 12 months)$4.37MNumber ofInstitutional Sellers(last 12 months)2TotalInstitutional Outflows(last 12 months)$4.26M Get PYXS Insider Trade Alerts Want to know when executives and insiders are buying or selling Pyxis Oncology stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data PYXS Institutional Buying and Selling by Quarter Ad Banyan Hill PublishingDon’t Miss Out on the AI Gold Rush That’s Just Getting Started“Titan of Tech” Bets Big on Tiny AI Company He’s made as much as 3,250,000% in just three years on companies like Facebook, Airbnb, and PayPal… But our research shows his latest investment could be his most successful venture yet.See how you can invest alongside him Pyxis Oncology Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails2/20/2024Cable Car Capital LLC61,606$111K0.1%N/A0.139% 2/14/2024Vestal Point Capital LP440,000$792K0.1%N/A0.993% 2/12/2024Decheng Capital LLC326,810$588K0.2%N/A0.737% 1/31/2024abrdn plc708,303$1.28M0.0%N/A1.598% 11/29/2023Decheng Capital Management III Cayman LLC326,810$650K0.2%N/A0.737% 11/15/2023Radcliffe Capital Management L.P.53,288$106K0.0%N/A0.120% Get the Latest News and Ratings for PYXS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Pyxis Oncology and its competitors with MarketBeat's FREE daily newsletter. 11/14/2023Schulhoff & Co. Inc.22,000$44K0.0%N/A0.050% 11/13/2023Acadian Asset Management LLC13,233$26K0.0%N/A0.030% 10/23/2023Commonwealth Equity Services LLC12,950$26K0.0%N/A0.033% 8/14/2023Prelude Capital Management LLC10,352$27K0.0%N/A0.027% 8/11/2023Harvest Investment Services LLC116,428$298K0.2%+27.9%0.304% 8/11/2023ExodusPoint Capital Management LP259,561$664K0.0%+270.8%0.679% 8/10/2023Cetera Investment Advisers18,260$47K0.0%N/A0.048% 7/10/2023SG Americas Securities LLC20,497$52K0.0%N/A0.054% 5/16/2023Hhlr Advisors LTD.530,692$2.13M0.0%-30.6%1.435% 5/4/2023Barclays PLC118,223$474K0.0%-87.5%0.320% 4/27/2023Simplicity Solutions LLC18,110$73K0.0%N/A0.049% 2/15/2023Tang Capital Management LLC3,470,700$4.65M0.7%+145.9%9.888% 2/9/2023Citigroup Inc.357,537$479K0.0%+14.5%1.019% 1/12/2023Marquette Asset Management LLC58,862$79K0.0%N/A0.168% 11/15/2022Tang Capital Management LLC1,411,569$2.78M0.3%+2.4%4.022% 11/14/2022RA Capital Management L.P.764,653$1.51M0.0%-19.8%2.179% 8/15/2022Acuta Capital Partners LLC645,149$1.54M0.9%+222.6%1.966% 8/15/2022Laurion Capital Management LP3,170,803$7.55M0.1%+159.9%9.662% 5/16/2022Ghost Tree Capital LLC75,000$303K0.1%-74.6%0.228% 5/13/2022Tekla Capital Management LLC708,303$2.63M0.1%+424.7%2.157% 2/16/2022Ghost Tree Capital LLC295,000$3.24M1.2%N/A0.900% 2/15/2022Laurion Capital Management LP1,162,332$12.75M0.1%N/A3.548% 2/15/2022Davidson Kempner Capital Management LP10,000$109K0.0%N/A0.031% 2/14/2022Citadel Advisors LLC1,521,617$16.48M0.0%N/A4.644% 2/14/2022Deerfield Management Company L.P. Series C311,754$3.42M0.1%N/A0.952% 2/14/2022Hhlr Advisors LTD.764,406$8.39M0.1%N/A2.333% 2/14/2022Perceptive Advisors LLC1,944,114$21.33M0.3%N/A5.934% 2/14/2022Sandia Investment Management LP10,000$110K0.0%N/A0.031% 2/14/2022Ghisallo Capital Management LLC30,000$329K0.0%N/A0.092% 2/8/2022Northern Trust Corp89,235$979K0.0%N/A0.272% 2/2/2022New York State Common Retirement Fund6,277$69K0.0%N/A0.019% (Data available from 1/1/2016 forward) PYXS Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of PYXS shares? During the previous two years, 25 institutional investors and hedge funds held shares of Pyxis Oncology. The most heavily invested institutionals were Laurion Capital Management LP ($7.55M), Tang Capital Management LLC ($4.65M), Tekla Capital Management LLC ($2.63M), Hhlr Advisors LTD. ($2.13M), Acuta Capital Partners LLC ($1.54M), RA Capital Management L.P. ($1.51M), and abrdn plc ($1.28M).Learn more on PYXS's institutional investors. What percentage of Pyxis Oncology stock is owned by institutional investors? 39.09% of Pyxis Oncology stock is owned by institutional investors. Learn more on PYXS's institutional investor holdings. Which institutional investors have been buying Pyxis Oncology stock? Of the 21 institutional investors that purchased Pyxis Oncology stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Tang Capital Management LLC ($2.09M), Laurion Capital Management LP ($1.95M), abrdn plc ($708.30K), Tekla Capital Management LLC ($573.30K), Acuta Capital Partners LLC ($445.15K), Vestal Point Capital LP ($440K), and Decheng Capital LLC ($326.81K). How much institutional buying is happening at Pyxis Oncology? Institutional investors have bought a total of 7,412,295 shares in the last 24 months. This purchase volume represents approximately $15.35M in transactions. Which Pyxis Oncology major shareholders have been selling company stock? The following institutional investors have sold Pyxis Oncology stock in the last 24 months: Barclays PLC ($829.83K), Hhlr Advisors LTD. ($233.71K), Ghost Tree Capital LLC ($220K), and RA Capital Management L.P. ($188.74K). How much institutional selling is happening at Pyxis Oncology? Institutional investors have sold a total of 1,472,282 shares in the last 24 months. This volume of shares sold represents approximately $5.53M in transactions. Related Companies: XBIT Major Shareholders NKTR Major Shareholders PRLD Major Shareholders VSTM Major Shareholders KMDA Major Shareholders AQST Major Shareholders RAPT Major Shareholders XOMA Major Shareholders AEON Major Shareholders NBTX Major Shareholders This page (NASDAQ:PYXS) was last updated on 4/23/2024 by MarketBeat.com Staff From Our PartnersThe A.I. story nobody is telling you (Read ASAP)TradeSmithHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill Publishingtop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsExposed: 10 CENT Crypto to Explode April 20th?True Market Insiders[Shocking] Elon Musk’s Plan To End BanksCrypto 101 Media Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Pyxis Oncology, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.